Invention Grant
- Patent Title: Modified oligonucleotides and methods of use
-
Application No.: US17063080Application Date: 2020-10-05
-
Publication No.: US12077757B2Publication Date: 2024-09-03
- Inventor: Sergei Gryaznov , Leonid Beigelman , Antitsa Dimitrova Stoycheva , Saul Martinez Montero , Jin Hong , Rajendra K. Pandey , Vivek Kumar Rajwanshi , Lakshmipathi Pandarinathan , Yi Jin , Bharat Baral
- Applicant: Janssen Biopharma, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Agency: Arnold & Porter Kaye Scholer LLP
- Main IPC: C07H21/02
- IPC: C07H21/02 ; A61K31/712 ; A61K31/7125 ; A61K47/54 ; A61P31/20 ; C12N15/11 ; C12N15/113
Abstract:
Modified oligonucleotides comprising modifications at the 2′ and/or 3′ position(s) along with methods of making and use, e.g., against HBV are disclosed.
Public/Granted literature
- US20210040483A1 MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE Public/Granted day:2021-02-11
Information query
